Jeffrey G. Shanes

1.5k total citations
18 papers, 472 citations indexed

About

Jeffrey G. Shanes is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Jeffrey G. Shanes has authored 18 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Surgery. Recurrent topics in Jeffrey G. Shanes's work include Cardiac Imaging and Diagnostics (7 papers), Heart Failure Treatment and Management (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Jeffrey G. Shanes is often cited by papers focused on Cardiac Imaging and Diagnostics (7 papers), Heart Failure Treatment and Management (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Jeffrey G. Shanes collaborates with scholars based in United States and United Kingdom. Jeffrey G. Shanes's co-authors include Jalal K. Ghali, Jeffrey E. Saffitz, J J Fenoglio, V J Ferrans, Chun‐Yen Tsai, Jean‐Charles Isner, M E Billingham, William D. Edwards, S H Kubo and Robert C. Bourge and has published in prestigious journals such as Circulation, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

Jeffrey G. Shanes

18 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey G. Shanes United States 10 383 96 77 48 36 18 472
Howard M. Waldman United States 8 351 0.9× 59 0.6× 124 1.6× 80 1.7× 13 0.4× 10 424
A Marzocchi Italy 11 304 0.8× 145 1.5× 206 2.7× 28 0.6× 9 0.3× 43 502
Brenda Moura Portugal 11 265 0.7× 29 0.3× 62 0.8× 43 0.9× 13 0.4× 40 364
Show Hong Duh United States 7 231 0.6× 132 1.4× 65 0.8× 25 0.5× 5 0.1× 9 368
Eisaku Nakane Japan 10 220 0.6× 46 0.5× 40 0.5× 50 1.0× 10 0.3× 40 310
Marcus A. Urey United States 7 273 0.7× 20 0.2× 60 0.8× 63 1.3× 25 0.7× 32 458
Neeraj Parakh India 12 204 0.5× 32 0.3× 85 1.1× 63 1.3× 9 0.3× 52 514
Eugene L. Coodley United States 12 75 0.2× 42 0.4× 65 0.8× 77 1.6× 9 0.3× 35 324
S Milo Israel 13 187 0.5× 37 0.4× 299 3.9× 182 3.8× 13 0.4× 26 496
Jacob Thorsted Sørensen Denmark 14 357 0.9× 167 1.7× 108 1.4× 29 0.6× 4 0.1× 36 485

Countries citing papers authored by Jeffrey G. Shanes

Since Specialization
Citations

This map shows the geographic impact of Jeffrey G. Shanes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey G. Shanes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey G. Shanes more than expected).

Fields of papers citing papers by Jeffrey G. Shanes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey G. Shanes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey G. Shanes. The network helps show where Jeffrey G. Shanes may publish in the future.

Co-authorship network of co-authors of Jeffrey G. Shanes

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey G. Shanes. A scholar is included among the top collaborators of Jeffrey G. Shanes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey G. Shanes. Jeffrey G. Shanes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shanes, Jeffrey G.. (2011). A Review of the Rationale for Additional Therapeutic Interventions to Attain Lower LDL-C When Statin Therapy Is Not Enough. Current Atherosclerosis Reports. 14(1). 33–40. 15 indexed citations
2.
Shanes, Jeffrey G., et al.. (2007). Statin therapy in heart failure: Prognostic effects and potential mechanisms. American Heart Journal. 154(4). 617–623. 18 indexed citations
4.
Mirvis, David M., Michael J. Boland, Michael P. Cinquegrani, et al.. (1990). Chronic Therapy for Congestive Heart Failure with Benazepril HCl, a New Angiotensin Converting Enzyme Inhibitor. The American Journal of the Medical Sciences. 300(6). 354–360. 3 indexed citations
5.
Mirvis, David M., Michael J. Boland, Michael P. Cinquegrani, et al.. (1989). A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure. Clinical Pharmacology & Therapeutics. 45(3). 312–320. 18 indexed citations
6.
Shanes, Jeffrey G., et al.. (1988). Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: Relevance of intrinsic sympathomimetic activity. American Heart Journal. 116(5). 1268–1275. 5 indexed citations
7.
Shanes, Jeffrey G., Jalal K. Ghali, M E Billingham, et al.. (1987). Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.. Circulation. 75(2). 401–405. 161 indexed citations
9.
Shanes, Jeffrey G., et al.. (1987). The value of routine right heart catheterization in patients undergoing coronary arteriography. American Heart Journal. 113(5). 1261–1263. 9 indexed citations
10.
Schrader, Bruce J., et al.. (1986). Acceptance of Transcutaneous Nitroglycerin Patches by Patients with Angina Pectoris. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 6(2). 83–86. 4 indexed citations
11.
Anders, Robert J., et al.. (1986). Lower incidence of doxorubicin-induced cardiomyopathy by once-a-week low-dose administration. American Heart Journal. 111(4). 755–759. 15 indexed citations
12.
Rich, Stuart, et al.. (1986). Determination of left ventricular ejection fraction using ultrafast computed tomography. American Heart Journal. 112(2). 392–396. 32 indexed citations
13.
Shanes, Jeffrey G., George T. Kondos, Sidney Levitsky, et al.. (1985). Coronary artery obstruction: A potentially reversible cause of dilated cardiomyopathy. American Heart Journal. 110(1). 173–178. 8 indexed citations
14.
Shanes, Jeffrey G., Ronald J. Krone, Cheng C. Tsai, Keith Fischer, & George A. Williams. (1984). Mild myocardial inflammation presenting as congestive cardiomyopathy responsive to immunosuppression. American Heart Journal. 107(4). 798–801. 9 indexed citations
15.
Shanes, Jeffrey G., et al.. (1984). Persistent endomyocardial biopsy-proven vasculitis following cure of endocarditis. American Heart Journal. 108(3). 614–619. 3 indexed citations
16.
Fleming, Gregory A. & Jeffrey G. Shanes. (1984). Left ventriculography induced coronary artery spasm. Clinical Cardiology. 7(10). 560–562. 9 indexed citations
17.
Shanes, Jeffrey G., et al.. (1983). Noninvasive ergonovine maleate provocative testing for coronary artery spasm: The need for routine thallium‐201 imaging. Catheterization and Cardiovascular Diagnosis. 9(3). 271–282. 3 indexed citations
18.
Shanes, Jeffrey G., Sidney Levitsky, Masud Seyal, et al.. (1983). Diagnosis of left ventricular to right atrial shunt utilizing contrast echocardiography. The American Journal of Cardiology. 52(5). 650–650. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026